Select a community
Parkinson's
Find out more about the PatientsLikeMe
Parkinson's Community
Home > Community Treatment Reports > Rasagiline Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Rasagiline Treatment Report

Brand Names: Azilect, Agilect

What is Rasagiline? Rasagiline is an anti-Parkinson's agent and MAO inhibitor which can enhance the activity of dopamine. It is used for initial monotherapy or as adjunct to levodopa in the treatment of idiopathic Parkinson's disease.

See more information, including instructions, precautions, side effects, and interactions.


Reasons taken

575 patients in the community are taking or have taken Rasagiline.

Top 10 (Show all)

Reason # Patients Percentage of patients
Treat Parkinson's 388 67%
Other 27 4%
Stiffness/Spasticity 14 2%
Support another treatment 11 1%
disease-related symptoms 3 <1%
Mobility 3 <1%
Slowness 2 <1%
Don't know 2 <1%
Tremors 2 <1%
Anxiety 2 <1%

Other treatments patients are taking for Treat Parkinson's include Carbidopa-Levodopa, Ropinirole, and Pramipexole.

Dosages

Based on the patients currently taking Rasagiline.

Top 10 (Show all)

All (Show top 10)

  daily 0.05 mg daily 0.3 mg daily 0.5 mg daily 1 mg daily 1.5 mg daily 2 mg daily 3 mg daily 5 mg daily 6 mg daily 1000 mg daily
  19 Number of Patients: 19 2 Number of Patients: 2 1 Number of Patients: 1 73 Number of Patients: 73 385 Number of Patients: 385 3 Number of Patients: 3 4 Number of Patients: 4 2 Number of Patients: 2 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Rasagiline or how long patients were taking Rasagiline before stopping.

Currently Taking Rasagiline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
2
20
22
78
92
112

Stopped Taking Rasagiline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
15
22
15
15
13
7
Why Patients Stopped Taking Rasagiline (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 38 43% Side effects too severe: 43%
Did not seem to work 36 41% Did not seem to work: 41%
Doctor's advice 22 25% Doctor's advice: 25%
Other 14 16% Other: 16%
Expense 8 9% Expense: 9%
Personal research 7 8% Personal research: 8%
Not indicated 1 1% Not indicated: 1%

Patient Reported Evaluations

Results from 137 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 27% 29
Moderate 25% 27
Slight 17% 18
None 8% 9
Can't tell 24% 26

Treat Parkinson's

Side-effects (as an overall problem)

Severe 6% 8
Moderate 7% 10
Mild 17% 23
None 70% 96

Top reported side-effects include: Urinary frequency, Anxiety, Headaches

Summary results are based on 137 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 137)

  • ronnie
    Sex: F
    Mouth/throat: none
    Arms: mild
    Chest: none
    Legs: mild
    See profile
  • ronnie
  • by ronnie
    Aug 19, 2008
  • EfficacyMajor
  • Side-effectsNone
  • Treat Parkinson's

  • Ladyhawk
    Sex: F
    Mouth/throat: none
    Arms: none
    Chest: none
    Legs: mild
    See profile
  • Ladyhawk
  • by Ladyhawk
    Aug 20, 2008
  • EfficacySlight
  • Side-effectsNone
  • Treat Parkinson's

See all evaluation results for Rasagiline

Report created on November 08, 2009.